Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents
作者:Carlos Velázquez、P.N. Praveen Rao、Robert McDonald、Edward E. Knaus
DOI:10.1016/j.bmc.2005.02.034
日期:2005.4
methanesulfonyl regioisomers 13a,b [COX-1 IC50=11.6 microM; COX-2 IC50=0.12 microM; COX-2 selectivity index (SI)=97] and aminosulfonyl regioisomers 16 (COX-1 IC50=9.8 microM; COX-2 IC50=0.78 microM; COX-2 SI=12), like the reference drug celecoxib (COX-1 IC50=33.1 microM; COX-2 IC50=0.07 microM; COX-2 SI=472), were potent in vitro COX-2 inhibitors with a good COX-2 selectivity index. Release of nitric oxide (NO)
一组3,4-二苯基-1,2,5-恶二唑-2-氧化物(3,4-二苯基呋喃烷)和相应的N-脱氧3,4-二苯基-1,2,5-恶二唑(3,4合成了(-diphenylfurazans)类似物,作为杂化环氧合酶(COX)抑制剂/一氧化氮供体试剂进行了体外评估。1- [4-(甲基磺酰基)苯基] -2-苯基乙烯与亚硝酸钠的乙酸水溶液反应,得到了不可分离的4- [4-(甲基磺酰基)苯基] -3-的混合物(3∶1的比例)。苯基-1,2,5-恶二唑-2-氧化物(13a)和3- [4-(甲基磺酰基)苯基] -4-苯基-1,2,5-恶二唑-2-氧化物(13b)区域异构体。通过未取代的3的氯磺化反应获得一组具有对氨基磺酰基苯基(16)或对叠氮磺酰基苯基(17)部分的相关区域异构体,4-二苯基呋喃烷(10),然后分别与氢氧化铵或叠氮化钠反应。甲磺酰基区域异构体13a,b [COX-1 IC50 = 11.6 microM;